Potential anti-cancer effect of curcumin in human lung squamous cell carcinoma

Thoracic Cancer

Volumn 6, Issue 4, 2015, Pages 508-516

  Zhao, Wei ^a   Wang, Yan ^a   Wang, Ying ^b   Gao, Nan ^a   Han, Zhifeng ^a   Yu, Haixiang ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b Jilin Province   (China)

Author keywords

Curcumin; Enrichment analysis; Lung squamous cell carcinoma; Protein protein interaction; RNA sequencing

Indexed keywords

EID: 84934439977     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/1759-7714.12222     Document Type: Article

References (49)

1. Cancer Gene Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. (Published erratum appears in Nature 2012; 491: 288) Nature 2012; 489: 519-525.
2. Hirsh F, Corrin B, Colby T. Clinical features and staging. In Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon 2004; 16-19.
3. Shi I, Hashemi Sadraei N, Duan ZH, Shi T. Aberrant signaling pathways in squamous cell lung carcinoma. Cancer Inform 2011; 10: 273-285.
4. Li Z, Guan W, Li MX etal. Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population. Arch Med Res 2011; 42: 226-234.
5. Harada D, Takigawa N, Kiura K. The role of STAT3 in non-small cell lung cancer. Cancers 2014; 6: 708-722.
6. Manju V, Nalini N. Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, post-initiation stages of 1, 2 dimethylhydrazine-induced colon cancer. Clin Chim Acta 2005; 358: 60-67.
7. Yang CL, Liu YY, Ma YG etal. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One 2012; 7(5): e37960.
8. Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett 2004; 215: 129-140.
9. Li ZC, Zhang LM, Wang HB, Ma JX, Sun JZ. Curcumin inhibits lung cancer progression and metastasis through induction of FOXO1. Tumor Biol 2014; 35: 111-116.
10. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009; 10: 57-63.
11. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013; 14: R36.
12. Trapnell C. Cuffdiff Documentation, v7? Open Module on GenePattern Public Server [Cited 2 Aug 2014]. Available from URL: http://www.broadinstitute.org/cancer/software/genepattern/modules/docs/Cuffdiff/7
13. Seyednasrollah F, Laiho A, Elo LL. Comparison of software packages for detecting differential expression in RNA-seq studies. Brief Bioinform 2013; doi: 10.1093/bib/bbt086.
14. Dennis G Jr, Sherman BT, Hosack DA etal. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
15. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2011; 40: D109-114.
16. Gene Ontology Consortium. Gene ontology annotations and resources. Nucleic Acids Res 2013; 41: D530-535.
17. Franceschini A, Szklarczyk D, Frankild S etal. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013; 41: D808-815.
18. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011; 27: 431-432.
19. Kim Y, Hammerman PS, Kim J etal. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. J Clin Oncol 2014; 32: 121-128.
20. Saha A, Kuzuhara T, Echigo N, Fujii A, Suganuma M, Fujiki H. Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of "growth arrest and DNA damage inducible genes 45 and 153." Biol Pharm Bull 2010; 33: 1291-1299.
21. Chen HW, Lee JY, Huang JY etal. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 2008; 68: 7428-7438.
22. Hoeijmakers JH. DNA damage, aging, and cancer. (Published erratum appears in N Engl J Med 2009; 361: 1914) N Engl J Med 2009; 361: 1475-1485.
23. Frosina G, Fortini P, Rossi O etal. Two pathways for base excision repair in mammalian cells. J Biol Chem 1996; 271: 9573-9578.
24. Bhattacharyya N, Banerjee S. Analysis of alterations in a base-excision repair gene in lung cancer. Methods Mol Med 2003; 74: 413-438.
25. Matsumoto Y. Molecular mechanism of PCNA-dependent base excision repair. Prog Nucleic Acid Res Mol Biol 2001; 68: 129-138.
26. Nemec AA, Wallace SS, Sweasy JB. Variant base excision repair proteins: Contributors to genomic instability. Semin Cancer Biol 2010; 20: 320-328.
27. Roy M, Sinha D, Mukherjee S, Biswas J. Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur J Cancer Prev 2011; 20: 123-131.
28. Sen B, Peng S, Woods DM etal. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. Clin Cancer Res 2012; 18: 127-139.
29. Schmidt JW, Sakamoto K, Creamer BA, Leone G, Wagner KU. Stat5 regulates the PI3-Kinase/Akt1 pathway during mammary gland development and promotes neoplastic transformation in a mouse model for Cowden syndrome. Cancer Res 2011; 71: Abstract P4-03-01.
30. Das M, Wakelee H. Targeting VEGF in lung cancer. Expert Opin Ther Targets 2012; 16: 395-406.
31. Ferrara N, Mass RD, Campa C, Kim R. Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu Rev Med 2007; 58: 491-504.
32. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
33. Chen CH, Lai JM, Chou TY etal. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PLoS One 2009; 4(4): e5052.
34. Chen XL, Nam JO, Jean C etal. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 2012; 22: 146-157.
35. Binion DG, Otterson MF, Rafiee P. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut 2008; 57: 1509-1517.
36. Karin M. Nuclear factor-κB in cancer development and progression. Nature 2006; 441: 431-436.
37. Tang X, Liu D, Shishodia S etal. Nuclear factor-κB (nf-κB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 2006; 107: 2637-2646.
38. Zhang J, Xu YJ, Zhang ZX etal. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues.] Zhonghua Jie He He Hu Xi Za Zhi 2007; 30: 771-775. (In Chinese.)
39. Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007; 26: 3279-3290.
40. Krens S, Spaink HP, Snaar-Jagalska BE. Functions of the MAPK family in vertebrate-development. FEBS Lett 2006; 580: 4984-4990.
41. Vicent S, Garayoa M, López-Picazo JM etal. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clin Cancer Res 2004; 10: 3639-3649.
42. Yan H, Zhu Y, Liu B etal. Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates. Br J Nutr 2011; 106: 1779-1791.
43. Lu Z, Ding L, Hong H, Hoggard J, Lu Q, Chen YH. Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway. Exp Cell Res 2011; 317: 1935-1946.
44. Sun Y, Cheng Z, Ma L, Pei G. β-Arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 2002; 277: 49212-49219.
45. Aggarwal BB, Shishodia S, Takada Y etal. Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 2005; 11: 7490-7498.
46. Matsuda A, Suzuki Y, Honda G etal. Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways. Oncogene 2003; 22: 3307-3318.
47. Sironi L, Banfi C, Brioschi M etal. Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment. Neurobiol Dis 2006; 22: 445-451.
48. Mattson MP, Camandola S. NF-κB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001; 107: 247-254.
49. Bava SV, Sreekanth CN, Thulasidasan AKT etal. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. Int J Biochem Cell Biol 2011; 43: 331-341.